Search Results

There are 23221 results for: content related to: High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada

  1. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Version of Record online : 8 JUN 2012, DOI: 10.1002/pds.3296

  2. You have full text access to this OnlineOpen article
    Association between drug-specific indicators of prescribing quality and quality of drug treatment: a validation study

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 9, September 2015, Pages: 906–914, Susanna M. Wallerstedt, Björn Belfrage and Johan Fastbom

    Version of Record online : 6 JUL 2015, DOI: 10.1002/pds.3827

  3. A critical review of methods to evaluate the impact of FDA regulatory actions

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 9, September 2013, Pages: 986–994, Becky A. Briesacher, Stephen B. Soumerai, Fang Zhang, Sengwee Toh, Susan E. Andrade, Joann L. Wagner, Azadeh Shoaibi and Jerry H. Gurwitz

    Version of Record online : 12 JUL 2013, DOI: 10.1002/pds.3480

  4. You have full text access to this OnlineOpen article
    Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 559–570, Cristina Varas-Lorenzo, Nuria Riera-Guardia, Brian Calingaert, Jordi Castellsague, Francesco Salvo, Federica Nicotra, Miriam Sturkenboom and Susana Perez-Gutthann

    Version of Record online : 25 APR 2013, DOI: 10.1002/pds.3437

  5. Selection bias in pharmacy-based patient surveys

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 2, February 2014, Pages: 128–139, P Frisk, S Kälvemark-Sporrong and B Wettermark

    Version of Record online : 30 AUG 2013, DOI: 10.1002/pds.3488

  6. The effect of obesity on antibiotic treatment failure: a historical cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 9, September 2013, Pages: 970–976, Cristina Longo, Gillian Bartlett, Brenda MacGibbon, Nancy Mayo, Ellen Rosenberg, Lyne Nadeau and Stella S. Daskalopoulou

    Version of Record online : 4 JUN 2013, DOI: 10.1002/pds.3461

  7. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 623–631, Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Version of Record online : 17 APR 2013, DOI: 10.1002/pds.3432

  8. Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 2, February 2014, Pages: 186–194, Paul Avillach, Francesco Salvo, Frantz Thiessard, Ghada Miremont-Salamé, Annie Fourrier-Reglat, Françoise Haramburu, Bernard Bégaud, Nicholas Moore, Antoine Pariente and on behalf of l'Association des Centres Régionaux de Pharmacovigilance

    Version of Record online : 14 MAY 2013, DOI: 10.1002/pds.3454

  9. Validation of asthma and eczema in population-based Swedish drug and patient registers

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 8, August 2013, Pages: 850–860, Anne K. Örtqvist, Cecilia Lundholm, Björn Wettermark, Jonas F. Ludvigsson, Weimin Ye and Catarina Almqvist

    Version of Record online : 11 JUN 2013, DOI: 10.1002/pds.3465

  10. Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996–2009

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 8, August 2013, Pages: 842–849, Maryam M. Asgari, Jashin J. Wu, Joel M. Gelfand, Craig Salman, Jeffrey R. Curtis, Leslie R. Harrold and Lisa J. Herrinton

    Version of Record online : 2 MAY 2013, DOI: 10.1002/pds.3447

  11. Use of antiepileptic drugs and risk of hypothyroidism

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 10, October 2013, Pages: 1071–1079, Edward Chia-Cheng Lai, Yea-Huei Kao Yang, Swu-Jane Lin and Cheng-Yang Hsieh

    Version of Record online : 15 AUG 2013, DOI: 10.1002/pds.3498

  12. Prescribing potentially inappropriate medication (PIM) in Germany's elderly as indicated by the PRISCUS list. An analysis based on regional claims data

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 7, July 2013, Pages: 719–727, Ingrid Schubert, Jutta Küpper-Nybelen, Peter Ihle and Petra Thürmann

    Version of Record online : 12 APR 2013, DOI: 10.1002/pds.3429

  13. Use of case–time–control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Pages: 1159–1170, Sylvie D. Price, C. D'Arcy J. Holman, Frank M. Sanfilippo and Jon D. Emery

    Version of Record online : 25 JUN 2013, DOI: 10.1002/pds.3469

  14. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 113–122, Hendrika J. Luijendijk, Niels C. de Bruin, Tessa A. Hulshof and Xander Koolman

    Version of Record online : 25 NOV 2015, DOI: 10.1002/pds.3912

  15. Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 9, September 2015, Pages: 980–990, Anaïs Lacasse, Mark A. Ware, Marc Dorais, Hélène Lanctôt and Manon Choinière

    Version of Record online : 24 JUN 2015, DOI: 10.1002/pds.3820

  16. Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 8, August 2016, Pages: 871–879, Javier Cid Ruzafa, Evie Merinopoulou, Rebecca F. Baggaley, Pamela Leighton, Winifred Werther, Diana Felici and Andrew Cox

    Version of Record online : 19 JAN 2016, DOI: 10.1002/pds.3927

  17. Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta-analysis

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 5, May 2014, Pages: 489–497, Supinya Dechanont, Sirada Maphanta, Bodin Butthum and Chuenjid Kongkaew

    Version of Record online : 10 MAR 2014, DOI: 10.1002/pds.3592

  18. Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 607–614, Angela S. Czaja, Robert J. Valuck and Heather D. Anderson

    Version of Record online : 4 MAR 2013, DOI: 10.1002/pds.3420

  19. Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 7, July 2013, Pages: 735–743, Susan E. Tett, Ingrid Sketris, Charmaine Cooke, Sander Veldhuyzen van Zanten and Nadia Barozzi

    Version of Record online : 4 APR 2013, DOI: 10.1002/pds.3442

  20. You have full text access to this OnlineOpen article
    Methodological gaps in the assessment of risk minimization interventions: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 572–579, Inna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, Camille Craig, Sarah Frise and Yola Moride

    Version of Record online : 24 FEB 2014, DOI: 10.1002/pds.3596